U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07640191) titled 'Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy' on June 03.
Brief Summary: The purpose of this study is to assess the safety and performance of the iVEAcare Neuromodulation System for the treatment of drug-resistant epilepsy.
The main questions it aims to answer are:
What medical problems do participants have when being implanted with and using the iVEAcare system? Does the iVEAcare neurostimulator reduce seizure frequency and severity in patients with drug-resistant epilepsy? Does the iVEAcare neurostimulator improve quality of life in patients with drug-resistant epilepsy?
...